NO991734D0 - Pyrazolinones for the treatment of potency disorders - Google Patents

Pyrazolinones for the treatment of potency disorders

Info

Publication number
NO991734D0
NO991734D0 NO991734A NO991734A NO991734D0 NO 991734 D0 NO991734 D0 NO 991734D0 NO 991734 A NO991734 A NO 991734A NO 991734 A NO991734 A NO 991734A NO 991734 D0 NO991734 D0 NO 991734D0
Authority
NO
Norway
Prior art keywords
pyrazolinones
treatment
potency disorders
potency
disorders
Prior art date
Application number
NO991734A
Other languages
Norwegian (no)
Other versions
NO991734L (en
Inventor
Michael Arlt
Rochus Jonas
Pierre Schelling
Maria Christadler
Franz-Werner Kluxen
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO991734D0 publication Critical patent/NO991734D0/en
Publication of NO991734L publication Critical patent/NO991734L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4152—1,2-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. antipyrine, phenylbutazone, sulfinpyrazone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO991734A 1996-10-14 1999-04-13 Pyrazolinones for the treatment of potency disorders NO991734L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19642284A DE19642284A1 (en) 1996-10-14 1996-10-14 Pyrazolinones for the treatment of erectile dysfunction
PCT/EP1997/005532 WO1998016224A1 (en) 1996-10-14 1997-10-08 Pyrazolinones to treat disturbances of potency

Publications (2)

Publication Number Publication Date
NO991734D0 true NO991734D0 (en) 1999-04-13
NO991734L NO991734L (en) 1999-04-13

Family

ID=7808669

Family Applications (1)

Application Number Title Priority Date Filing Date
NO991734A NO991734L (en) 1996-10-14 1999-04-13 Pyrazolinones for the treatment of potency disorders

Country Status (14)

Country Link
EP (1) EP0930881A1 (en)
JP (1) JP2001501958A (en)
KR (1) KR20000049086A (en)
CN (1) CN1233178A (en)
AR (1) AR008494A1 (en)
AU (1) AU4945297A (en)
BR (1) BR9712307A (en)
CA (1) CA2268823A1 (en)
DE (1) DE19642284A1 (en)
HU (1) HUP0000233A3 (en)
NO (1) NO991734L (en)
PL (1) PL332821A1 (en)
WO (1) WO1998016224A1 (en)
ZA (1) ZA979151B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6410584B1 (en) 1998-01-14 2002-06-25 Cell Pathways, Inc. Method for inhibiting neoplastic cells with indole derivatives
US6200771B1 (en) 1998-10-15 2001-03-13 Cell Pathways, Inc. Method of using a novel phosphodiesterase in pharmaceutical screeing to identify compounds for treatment of neoplasia
US6133271A (en) * 1998-11-19 2000-10-17 Cell Pathways, Inc. Method for inhibiting neoplastic cells and related conditions by exposure thienopyrimidine derivatives
US6187779B1 (en) 1998-11-20 2001-02-13 Cell Pathways, Inc. Method for inhibiting neoplastic cells and related conditions by exposure to 2,8-disubstituted quinazoline derivatives
US6369092B1 (en) 1998-11-23 2002-04-09 Cell Pathways, Inc. Method for treating neoplasia by exposure to substituted benzimidazole derivatives
US6486155B1 (en) 1998-11-24 2002-11-26 Cell Pathways Inc Method of inhibiting neoplastic cells with isoquinoline derivatives
US6034099A (en) * 1998-11-24 2000-03-07 Cell Pathways, Inc. Method for inhibiting neoplastic lesions by administering 4-(arylmethylene)- 2, 3- dihydro-pyrazol-3-ones
US6077842A (en) * 1998-11-24 2000-06-20 Cell Pathways, Inc. Method of inhibiting neoplastic cells with pyrazolopyridylpyridazinone derivatives
US6875575B1 (en) 1998-11-25 2005-04-05 Osi Pharmaceuticals, Inc. Diagnostic methods for neoplasia
US6020379A (en) * 1999-02-19 2000-02-01 Cell Pathways, Inc. Position 7 substituted indenyl-3-acetic acid derivatives and amides thereof for the treatment of neoplasia

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9311920D0 (en) * 1993-06-09 1993-07-28 Pfizer Ltd Therapeutic agents
DE19518082A1 (en) * 1995-05-17 1996-11-21 Merck Patent Gmbh 4 (-Arylaminomethylene) -2,4-dihydropyrazol-3-one

Also Published As

Publication number Publication date
EP0930881A1 (en) 1999-07-28
HUP0000233A3 (en) 2001-06-28
JP2001501958A (en) 2001-02-13
WO1998016224A1 (en) 1998-04-23
ZA979151B (en) 1998-05-11
AR008494A1 (en) 2000-01-19
PL332821A1 (en) 1999-10-11
CA2268823A1 (en) 1998-04-23
BR9712307A (en) 1999-08-31
AU4945297A (en) 1998-05-11
CN1233178A (en) 1999-10-27
DE19642284A1 (en) 1998-04-16
HUP0000233A2 (en) 2001-04-28
NO991734L (en) 1999-04-13
KR20000049086A (en) 2000-07-25

Similar Documents

Publication Publication Date Title
NO986052D0 (en) Anticonvulsant derivatives for the treatment of obesity
NO991955D0 (en) Process for the treatment of hydrocarbons
NO306977B1 (en) Use of thienol [1,5] benzodiazepine for the treatment of gastrointestinal disorders
NO970153L (en) Process for the Synthesis of Substituted Sulfoxides
NO965377L (en) Indolinone compounds for the treatment of diseases
IL129998A0 (en) Novel substituted pyrazole derivatives for the treatment of cardiocirculatory diseases
NO20003042L (en) Procedure for the prophylactic treatment of mastitis
NO991459L (en) Use of 1-hydroxy-2-pyridones for the treatment of skin infections
ID27214A (en) TRIAZOLOPIRIDINA FOR TREATMENT OF TROMBOSIS DISORDERS
NO991734D0 (en) Pyrazolinones for the treatment of potency disorders
NO984432D0 (en) Procedure for the treatment of migraine pain
NO996432D0 (en) Process for the preparation of 4-substituted-1H-indole-3-glycosamides
NO973366D0 (en) Procedure for the treatment of multiple sclerosis
NO985535D0 (en) Process for the preparation of 1,3-alkanediols
NO982562D0 (en) Composition for the treatment of pain
NO20012612D0 (en) Isonipecotamides for the treatment of integrin-mediated disorders
NO991158D0 (en) Procedure for the treatment of amyotrophic lateral sclerosis
NO984189D0 (en) Procedure for the treatment of bipolar disorder
NO953089L (en) Steroids for the treatment of menopausal disorders
NO993549D0 (en) Imino-aza-anthracycline derivatives for the treatment of amyloidosis
NO952411D0 (en) Means for the treatment of metabolic bone disorders
NO986053D0 (en) Anticonvulsant derivatives for the treatment of psoriasis
NO20003077D0 (en) Process for the preparation of the chlorobenzoxazole
NO962812D0 (en) Procedure for the treatment of pneumonia
NO994557D0 (en) Process for the preparation of arylaminotriazolopyridines